Markham Stouffville Hospital is an acute care community hospital with two sites: the Markham site, with diagnostic and emergency services, and clinical programs in childbirth, children's health, surgery, ...

There are 309 beds in Markham Stouffville Hospital.

During the past decade, Markham Stouffville Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Markham Stouffville Hospital" #1 sponsor was "NCIC Clinical Trials Group" with 3 trials, followed by "McMaster University" with 2 trials sponsored, "Ontario Clinical Oncology Group (OCOG)" with 2 trials sponsored, "The Hospital for Sick Children" with 2 trials sponsored and "AGO Study Group" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Markham Stouffville Hospital" #1 collaborator was "NCIC Clinical Trials Group" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Markham Stouffville Hospital" are "Breast Cancer" (3 trials), "COVID-19" (2 trials), "Hip Fractures" (2 trials), "Bladder Cancer" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "Markham Stouffville Hospital" in a lesser frequency.

Most popular intervention types in "Markham Stouffville Hospital" are "Drug" (10 trials), "Other" (6 trials), "Device" (3 trials), "Genetic" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Accelerated medical clearance and surgery" (2 trials), "gemcitabine hydrochloride" (2 trials), "Artesunate" (1 trials), "BUN adjustable fortification" (1 trials) and "Bovine protein-based fortifier" (1 trials). Other intervention names were less common.

The vast majority of trials in "Markham Stouffville Hospital" are 17 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Markham Stouffville Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Markham Stouffville Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Markham Stouffville Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".